Long Run Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-36,765
Closed -$3.66M 106
2024
Q4
$3.66M Buy
36,765
+5,134
+16% +$529K 0.88% 34
2024
Q3
$3.59M Buy
31,631
+4,027
+15% +$478K 0.85% 38
2024
Q2
$3.42M Buy
27,604
+201
+0.7% +$25.9K 0.87% 35
2024
Q1
$3.62M Buy
27,403
+874
+3% +$108K 0.95% 31
2023
Q4
$2.89M Buy
26,529
+2,535
+11% +$263K 0.84% 35
2023
Q3
$2.47M Buy
23,994
+1,135
+5% +$122K 0.8% 35
2023
Q2
$2.64M Buy
22,859
+369
+2% +$41.9K 0.84% 29
2023
Q1
$2.39M Sell
22,490
-983
-4% -$106K 0.81% 31
2022
Q4
$2.6M Buy
23,473
+249
+1% +$25.5K 0.94% 32
2022
Q3
$2M Sell
23,224
-1,707
-7% -$152K 0.79% 36
2022
Q2
$2.27M Sell
24,931
-822
-3% -$72.9K 0.88% 33
2022
Q1
$2.11M Buy
25,753
+755
+3% +$59.5K 0.74% 37
2021
Q4
$1.91M Buy
+24,998
New +$1.99M 0.66% 38

Other funds holding MRK

Long Run Wealth Advisors's MRK Position: Q1 2025 in Review

Long Run Wealth Advisors sold out of Merck (MRK) in Q1 2025, closing a stake of 36,765 shares — an estimated $3.66M sold.

Long Run Wealth Advisors first reported a position in MRK in Q4 2021 and held it in 13 quarters. The position peaked at $3.66M in Q4 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Long Run Wealth Advisors reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Long Run Wealth Advisors sold 36,765 Merck shares in Q1 2025, an estimated $3.66M.
  • Long Run Wealth Advisors first reported a position in Merck in Q4 2021 and held it in 13 quarters.
  • Long Run Wealth Advisors's Merck position peaked at $3.66M in Q4 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Long Run Wealth Advisors's 13F filing for Q1 2025, filed 10 Apr 2025.